1187 Antibody-lectin bispecifics for glyco-immune checkpoint blockade

• Nicholas Riley,
• Thomas Valerius,
• Jeffrey Ravetch,
• Jessica Stark,
• Carolyn R Bertozzi,
• Melissa Gray,
• Simon Wisnovsky,
• Itziar Ibarlucea-Benitez,
• Mikaela Ribi,
• Marta Lustig,
• Wesley Errington,
• Bence Bruncsics,
• Casim Sarkar

Affiliations

Nicholas Riley

Stanford University, Stanford, CA, USA

Thomas Valerius

Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, University Hospital Schleswig Holstein, Kiel, Germany

Jeffrey Ravetch

2The Rockefeller University, New York, NY, USA

Jessica Stark

Stanford University, Stanford, CA, USA

Carolyn R Bertozzi

Stanford University, Stanford, CA, USA

Melissa Gray

1Stanford University, Stanford, CA, USA

Simon Wisnovsky

1Stanford University, Stanford, CA, USA

Itziar Ibarlucea-Benitez

2The Rockefeller University, New York, NY, USA

Mikaela Ribi

1Stanford University, Stanford, CA, USA

Marta Lustig

3Christian Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Schleswig-Holstein, Germany

Wesley Errington

4University of Minnesota, Minneapolis, MN, USA

Bence Bruncsics

5Budapest University of Technology and Economics, Budapest, Hungary

Casim Sarkar

4University of Minnesota, Minneapolis, MN, USA